K. Hattori

发表

Effect of electroconvulsive therapy on gray matter volume in major depressive disorder.

Miho Ota, Hiroshi Kunugi, Noriko Sato, 2015, Journal of affective disorders.

Relationship between Autistic Spectrum Trait and Regional Cerebral Blood Flow in Healthy Male Subjects

H. Matsuda, M. Ota, Y. Kamio, 2018, Psychiatry investigation.

Correlation of reduced social communicational and interactional skills with regional grey matter volumes in schizophrenia patients

M. Ota, Y. Kamio, H. Kunugi, 2017, Acta Neuropsychiatrica.

Characteristic distributions of regional cerebral blood flow changes in major depressive disorder patients: a pseudo-continuous arterial spin labeling (pCASL) study.

M. Ota, H. Kunugi, H. Hori, 2014, Journal of affective disorders.

Altered Coupling of Regional Cerebral Blood flow and Brain Temperature in Schizophrenia Compared with Bipolar Disorder and Healthy Subjects

M. Ota, Kei Yamada, H. Kunugi, 2014, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Multimodal image analysis of sensorimotor gating in healthy women

Yasuhiro Nakata, Miho Ota, Satoko Obu, 2013, Brain Research.

Hypothalamic-Pituitary-Adrenal Axis Hyperactivity and Brain Differences in Healthy Women

M. Ota, H. Kunugi, H. Hori, 2013, Neuropsychobiology.

Plasma Metabolites Predict Severity of Depression and Suicidal Ideation in Psychiatric Patients-A Multicenter Pilot Analysis

Takahiro A. Kato, S. Kanba, R. Hashimoto, 2016, PloS one.

PS221. Major depressive disorder and initial insulin hyposecretion in oral glucose tolerance test

S. Yoshida, H. Kunugi, K. Hattori, 2016, International Journal of Neuropsychopharmacology.

Association of body mass index-related single nucleotide polymorphisms with psychiatric disease and memory performance in a Japanese population

S. Shibata, M. Ota, H. Kunugi, 2016, Acta Neuropsychiatrica.

Haplotype phasing of a bipolar disorder pedigree revealed rare multiple mutations of SPOCD1 gene in the 1p36-35 susceptibility locus.

H. Kunugi, R. Kimura, T. Kaname, 2022, Journal of affective disorders.

Plasma L-tryptophan concentration in major depressive disorder: new data and meta-analysis.

N. Motohashi, H. Kunugi, H. Hori, 2014, The Journal of clinical psychiatry.

Structural differences in hippocampal subfields among schizophrenia patients, major depressive disorder patients, and healthy subjects

M. Ota, H. Kunugi, H. Matsuda, 2017, Psychiatry Research: Neuroimaging.

Identification of Single Nucleotide Polymorphisms Regulating Peripheral Blood mRNA Expression with Genome-Wide Significance: An eQTL Study in the Japanese Population

M. Ota, H. Kunugi, H. Hori, 2013, PloS one.

The relationship between the Wechsler Memory Scale-Revised scores and whole-brain structure in patients with schizophrenia and healthy individuals

M. Ota, H. Kunugi, H. Hori, 2019, Cognitive neuropsychiatry.

Correlation Between the Wechsler Adult Intelligence Scale- 3rd Edition Metrics and Brain Structure in Healthy Individuals: A Whole-Brain Magnetic Resonance Imaging Study

M. Ota, Y. Yomogida, H. Kunugi, 2020, Frontiers in Human Neuroscience.

Manual dexterity and brain structure in patients with schizophrenia: A whole-brain magnetic resonance imaging study

M. Ota, H. Kunugi, D. Sasayama, 2018, Psychiatry Research: Neuroimaging.

Association between vascular endothelial growth factor-mediated blood–brain barrier dysfunction and stress-induced depression

K. Sohya, Kazunori O’Hashi, N. Ichinohe, 2022, Molecular Psychiatry.

Blood CADPS2ΔExon3 expression is associated with intelligence and memory in healthy adults

H. Kunugi, H. Hori, K. Hattori, 2012, Biological Psychology.

Genome-wide quantitative trait loci mapping of the human cerebrospinal fluid proteome

M. Ota, S. Yoshida, H. Kunugi, 2016, Human molecular genetics.

The common functional FKBP5 variant rs1360780 is associated with altered cognitive function in aged individuals

M. Ota, H. Kunugi, H. Hori, 2014, Scientific Reports.

Increased apolipoprotein E and decreased TNF‐α in the cerebrospinal fluid of nondemented APOE‐ε4 carriers

S. Yoshida, H. Kunugi, D. Sasayama, 2020, Neuropsychopharmacology reports.

Relationship between Interpersonal Sensitivity Measure score and clinical symptoms in patients with major psychiatric disorders and healthy individuals

M. Ota, H. Kunugi, K. Hattori, 2022, Psychiatry and Clinical Neurosciences Reports.

A polymorphism of the methylenetetrahydrofolate reductase gene confers susceptibility to schizophrenia and related brain changes

M. Ota, H. Kunugi, N. Sato, 2019, Schizophrenia Research.

Elevated Cortisol Level and Cortisol/DHEAS Ratio in Schizophrenia as Revealed by Low-Dose Dexamethasone Suppression Test

H. Kunugi, H. Hori, D. Sasayama, 2012 .

Possible association between common variants of the phenylalanine hydroxylase (PAH) gene and memory performance in healthy adults

M. Ota, H. Kunugi, H. Hori, 2013, Behavioral and Brain Functions.

Characterization of Postprandial Effects on CSF Metabolomics: A Pilot Study with Parallel Comparison to Plasma

Kosuke Saito, H. Kunugi, Tomohiro Andou, 2020, Metabolites.

Association of body mass index and its classifications with gray matter volume in individuals with a wide range of body mass index group: A whole-brain magnetic resonance imaging study

M. Ota, Y. Yomogida, H. Kunugi, 2022, Frontiers in Human Neuroscience.

The relationship between circulating mitochondrial DNA and inflammatory cytokines in patients with major depression.

T. Kinoshita, S. Yoshida, Tadafumi Kato, 2017, Journal of affective disorders.

Eicosapentaenoic Acid Intake Associated with Reduced Risk of Posttraumatic Stress Disorder after the Great East Japan Earthquake and Tsunami

T. Asada, M. Ota, H. Kunugi, 2019, Psychological Trauma.

Increased Protein and mRNA Expression of Resistin After Dexamethasone Administration

M. Ota, H. Kunugi, H. Hori, 2014, Hormone and Metabolic Research.

Effect of the common functional FKBP5 variant (rs1360780) on the hypothalamic-pituitary-adrenal axis and peripheral blood gene expression

M. Ota, H. Kunugi, H. Hori, 2014, Psychoneuroendocrinology.

Defective neocortical development in Fyn-tyrosine-kinase-deficient mice

T. Yagi, K. Hattori, S. Yuasa, 2004, Neuroreport.

Association between vascular endothelial growth factor-mediated blood–brain barrier dysfunction and stress-induced depression

K. Sohya, Kazunori O’Hashi, N. Ichinohe, 2022, Molecular Psychiatry.

Plasma neuropeptide levels in patients with schizophrenia, bipolar disorder, or major depressive disorder and healthy controls: A multiplex immunoassay study

H. Kunugi, K. Hattori, J. Matsuo, 2022, Neuropsychopharmacology reports.

Fyn Is Required for Haloperidol-induced Catalepsy in Mice*

M. Iyo, T. Yagi, S. Kohsaka, 2006, Journal of Biological Chemistry.

Soluble APP-α and APP-β in cerebrospinal fluid as potential biomarkers for differential diagnosis of mild cognitive impairment

S. Yoshida, H. Mizusawa, S. Murayama, 2021, Aging Clinical and Experimental Research.

Increased cerebrospinal fluid complement C5 levels in major depressive disorder and schizophrenia.

A. Nunomura, M. Ota, S. Yoshida, 2018, Biochemical and biophysical research communications.

Role of NMDA receptor subtypes in the induction of catalepsy and increase in Fos protein expression after administration of haloperidol

K. Hashimoto, M. Iyo, K. Hattori, 2004, Brain Research.

Fyn kinase‐mediated phosphorylation of NMDA receptor NR2B subunit at Tyr1472 is essential for maintenance of neuropathic pain

Masahiko Watanabe, T. Yagi, M. Mishina, 2005, The European journal of neuroscience.

Possible impact of ADRB3 Trp64Arg polymorphism on BMI in patients with schizophrenia

M. Ota, H. Kunugi, H. Hori, 2012, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Possible association of Bifidobacterium and Lactobacillus in the gut microbiota of patients with major depressive disorder.

M. Ota, S. Yoshida, H. Kunugi, 2016, Journal of affective disorders.

FcɛRI-mediated mast cell degranulation requires calcium-independent microtubule-dependent translocation of granules to the plasma membrane

T. Yagi, R. Geha, T. Hirano, 2005, The Journal of cell biology.

13C-phenylalanine breath test and serum biopterin in schizophrenia, bipolar disorder and major depressive disorder.

M. Ota, H. Kunugi, Y. Ozeki, 2018, Journal of psychiatric research.

13C-phenylalanine breath test detects altered phenylalanine kinetics in schizophrenia patients

M. Ota, H. Kunugi, Y. Ozeki, 2012, Translational Psychiatry.

Comparative analysis of cerebrospinal fluid metabolites in Alzheimer’s disease and idiopathic normal pressure hydrocephalus in a Japanese cohort

K. Ozaki, M. Kayano, S. Niida, 2018, Biomarker Research.

Decreased expression of Fyn protein and disbalanced alternative splicing patterns in platelets from patients with schizophrenia

Takeshi Yagi, T. Yagi, S. Hamada, 2009, Psychiatry Research.

Effect of L‐theanine on sensorimotor gating in healthy human subjects

M. Ota, H. Kunugi, H. Hori, 2014, Psychiatry and clinical neurosciences.

Cerebrospinal fluid neural cell adhesion molecule levels and their correlation with clinical variables in patients with schizophrenia, bipolar disorder, and major depressive disorder

M. Ota, S. Yoshida, H. Kunugi, 2017, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Identification and characterization of coding single-nucleotide polymorphisms within human protocadherin-α and -β gene clusters

T. Hirabayashi, T. Yagi, Yusuke Taguchi, 2005 .

Genome-Wide Association Study Detected Novel Susceptibility Genes for Schizophrenia and Shared Trans-Populations/Diseases Genetic Effect.

Y. Kamatani, N. Kanahara, M. Kubo, 2018, Schizophrenia bulletin.

Relationship between Lifetime Suicide Attempts and Schizotypal Traits in Patients with Schizophrenia

M. Ota, H. Kunugi, H. Hori, 2014, PloS one.

Trait Loci Mapping and CSF Proteome.

H. Kunugi, D. Sasayama, K. Hattori, 2019, Methods in molecular biology.

Cerebrospinal fluid D-serine concentrations in major depressive disorder negatively correlate with depression severity.

T. Nishikawa, H. Kunugi, D. Sasayama, 2018, Journal of affective disorders.

Association of plasma IL-6 and soluble IL-6 receptor levels with the Asp358Ala polymorphism of the IL-6 receptor gene in schizophrenic patients.

K. Arima, M. Ota, H. Kunugi, 2011, Journal of psychiatric research.

Integrated profiling of phenotype and blood transcriptome for stress vulnerability and depression.

M. Ota, Yoshiharu Kim, H. Kunugi, 2018, Journal of psychiatric research.

ITIH3 polymorphism may confer susceptibility to psychiatric disorders by altering the expression levels of GLT8D1.

M. Ota, H. Kunugi, H. Hori, 2014, Journal of psychiatric research.

Cerebrospinal Fluid Inflammatory Cytokine Levels in Patients With Major Psychiatric Disorders: A Multiplex Immunoassay Study

M. Ota, S. Yoshida, H. Kunugi, 2021, Frontiers in Pharmacology.

Reduction of β-amyloid accumulation by reticulon 3 in transgenic mice.

R. Shin, A. Tamaoka, K. Ogino, 2013, Current Alzheimer research.

Reduction of beta-amyloid accumulation by reticulon 3 in transgenic mice

R. Shin, A. Tamaoka, K. Ogino, 2011, Alzheimer's & Dementia.

Investigating DNA Methylation of SHATI/NAT8L Promoter Sites in Blood of Unmedicated Patients with Major Depressive Disorder.

K. Ohi, R. Hashimoto, H. Yamamori, 2020, Biological & pharmaceutical bulletin.

Increased cerebrospinal fluid interleukin-6 levels in patients with schizophrenia and those with major depressive disorder.

Teruhiko Higuchi, Miho Ota, Hiroshi Kunugi, 2013, Journal of psychiatric research.

Effect of a ketogenic meal on cognitive function in elderly adults: potential for cognitive enhancement

Miho Ota, Hiroshi Kunugi, M. Ota, 2016, Psychopharmacology.

Identification and characterization of coding single-nucleotide polymorphisms within human protocadherin-alpha and -beta gene clusters.

T. Hirabayashi, T. Yagi, Yusuke Taguchi, 2005, Gene.

13C-tryptophan breath test detects increased catabolic turnover of tryptophan along the kynurenine pathway in patients with major depressive disorder

M. Ota, H. Kunugi, H. Hori, 2015, Scientific Reports.

Lower cerebrospinal fluid CRH concentration in chronic schizophrenia with negative symptoms.

S. Yoshida, H. Kunugi, D. Sasayama, 2020, Journal of psychiatric research.

Association between the common functional FKBP5 variant (rs1360780) and brain structure in a non-clinical population.

M. Ota, H. Kunugi, H. Hori, 2014, Journal of psychiatric research.

Discrimination between schizophrenia and major depressive disorder by magnetic resonance imaging of the female brain.

Teruhiko Higuchi, Yasuhiro Nakata, Miho Ota, 2013, Journal of psychiatric research.

Association between the scores of the Japanese version of the Brief Assessment of Cognition in Schizophrenia and whole‐brain structure in patients with chronic schizophrenia: A voxel‐based morphometry and diffusion tensor imaging study

M. Ota, H. Kunugi, K. Hattori, 2017, Psychiatry and clinical neurosciences.

chronic schizophrenia : a voxel-based morphometry and diffusion tensor imaging study Running title : BACS-J and whole-brain structure

M. Ota, H. Kunugi, K. Hattori, 2017 .

Search for plasma biomarkers in drug‐free patients with bipolar disorder and schizophrenia using metabolome analysis

N. Mataga, S. Yoshida, K. Kuroda, 2017, Psychiatry and clinical neurosciences.

NMDA-receptor proteins are upregulated in the hippocampus of postnatal heterozygous reeler mice

T. Yagi, K. Hattori, Tomoko Isosaka, 2006, Brain Research.

Glutamatergic changes in the cerebral white matter associated with schizophrenic exacerbation

M. Ota, H. Kunugi, H. Hori, 2012, Acta psychiatrica Scandinavica.

Benzodiazepines, benzodiazepine-like drugs, and typical antipsychotics impair manual dexterity in patients with schizophrenia.

K. Arima, M. Ota, H. Kunugi, 2014, Journal of psychiatric research.

Possible role of the dopamine D1 receptor in the sensorimotor gating deficits induced by high-fat diet

T. Numakawa, H. Kunugi, K. Hattori, 2015, Psychopharmacology.

Effect of l-theanine on glutamatergic function in patients with schizophrenia

M. Ota, H. Kunugi, H. Hori, 2015, Acta Neuropsychiatrica.

Phenotypic characterization of a new Grin1 mutant mouse generated by ENU mutagenesis

H. Masuya, S. Wakana, T. Noda, 2010, The European journal of neuroscience.

Reduced Cerebrospinal Fluid Levels of Lysophosphatidic Acid Docosahexaenoic Acid in Patients With Major Depressive Disorder and Schizophrenia

H. Kunugi, J. Aoki, K. Kano, 2021, The international journal of neuropsychopharmacology.

Reduced Serum and Cerebrospinal Fluid Levels of Autotaxin in Major Depressive Disorder

S. Yamawaki, S. Yoshida, H. Kunugi, 2019, The international journal of neuropsychopharmacology.

Comparative analysis of cerebrospinal fluid metabolites in Alzheimer’s disease and idiopathic normal pressure hydrocephalus in a Japanese cohort

K. Ozaki, M. Kayano, S. Niida, 2018, Biomarker Research.

Levels of lysophosphatidic acid in cerebrospinal fluid and plasma of patients with schizophrenia

Leo Gotoh, S. Yoshida, H. Kunugi, 2019, Psychiatry Research.

Association between lower estimated premorbid intelligence quotient and smoking behavior in patients with schizophrenia

M. Ota, H. Kunugi, K. Hattori, 2018, Schizophrenia Research: Cognition.

Moderating effect of schizotypy on the relationship between smoking and neurocognition

M. Ota, H. Kunugi, H. Hori, 2013, European Psychiatry.

Possible association between Interleukin-1beta gene and schizophrenia in a Japanese population

M. Ota, H. Kunugi, H. Hori, 2011, Behavioral and Brain Functions.

Blood-based gene expression signatures of medication-free outpatients with major depressive disorder: integrative genome-wide and candidate gene analyses

M. Ota, Yoshiharu Kim, H. Kunugi, 2016, Scientific Reports.

Activation of Fyn tyrosine kinase in the mouse dorsal hippocampus is essential for contextual fear conditioning

T. Yagi, S. Kida, T. Kohno, 2008, The European journal of neuroscience.

Possible association between common variants of the phenylalanine hydroxylase (PAH) gene and memory performance in healthy adults

M. Ota, H. Kunugi, H. Hori, 2013, Behavioral and Brain Functions.

Nervonic acid level in cerebrospinal fluid is a candidate biomarker for depressive and manic symptoms: A pilot study

S. Yoshida, Tadafumi Kato, Koki Inoue, 2021, Brain and behavior.

Association between the functional polymorphism (C3435T) of the gene encoding P-glycoprotein (ABCB1) and major depressive disorder in the Japanese population.

M. Ota, H. Kunugi, H. Hori, 2012, Journal of psychiatric research.

A personality-based latent class typology of outpatients with major depressive disorder: association with symptomatology, prescription pattern and social function.

M. Ota, Yoshiharu Kim, H. Kunugi, 2017, Journal of affective disorders.

Association between obesity and white matter microstructure impairments in patients with schizophrenia: A whole-brain magnetic resonance imaging study

M. Ota, Y. Yomogida, H. Kunugi, 2020, Schizophrenia Research.

Cerebrospinal fluid BDNF pro-peptide levels in major depressive disorder and schizophrenia.

S. Yoshida, H. Kunugi, M. Kojima, 2019, Journal of psychiatric research.

Bifidobacterium and Lactobacillus Counts in the Gut Microbiota of Patients With Bipolar Disorder and Healthy Controls

M. Ota, S. Yoshida, H. Kunugi, 2019, Front. Psychiatry.

Association between the Pittsburgh sleep quality index and white matter integrity in healthy adults: a whole-brain magnetic resonance imaging study

M. Ota, Y. Yomogida, H. Kunugi, 2023, Sleep and Biological Rhythms.

Association of obesity with cognitive function and brain structure in patients with major depressive disorder.

M. Ota, S. Yoshida, H. Kunugi, 2018, Journal of affective disorders.

Auditory-conditioned-fear-dependent c-Fos expression is altered in the emotion-related brain structures of Fyn-deficient mice.

K. Hashimoto, M. Iyo, T. Yagi, 2004, Brain research. Molecular brain research.

Re-evaluation of soluble APP-α and APP-β in cerebrospinal fluid as potential biomarkers for early diagnosis of dementia disorders

K. Ishii, H. Matsuda, K. Arima, 2017, Biomarker Research.

Low cocaine- and amphetamine-regulated transcript (CART) peptide levels in human cerebrospinal fluid of major depressive disorder (MDD) patients.

H. Kunugi, D. Sasayama, K. Hattori, 2018, Journal of affective disorders.

Altered polyunsaturated fatty acid levels in relation to proinflammatory cytokines, fatty acid desaturase genotype, and diet in bipolar disorder

H. Kunugi, H. Hori, K. Hattori, 2019, Translational Psychiatry.

Brain-Derived Major Glycoproteins Are Possible Biomarkers for Altered Metabolism of Cerebrospinal Fluid in Neurological Diseases

M. Miyajima, H. Arai, N. Araki, 2023, International journal of molecular sciences.

Plasma amino acid profile in major depressive disorder: Analyses in two independent case-control sample sets.

M. Ota, S. Yoshida, H. Kunugi, 2018, Journal of psychiatric research.

Reduced cerebrospinal fluid ethanolamine concentration in major depressive disorder

M. Ota, Y. Ohashi, N. Motohashi, 2015, Scientific Reports.

Poor sleep is associated with exaggerated cortisol response to the combined dexamethasone/CRH test in a non-clinical population.

H. Kunugi, Y. Ozeki, H. Hori, 2011, Journal of psychiatric research.

Pseudo-continuous arterial spin labeling MRI study of schizophrenic patients

M. Ota, H. Kunugi, H. Hori, 2014, Schizophrenia Research.

PTPRQ as a potential biomarker for idiopathic normal pressure hydrocephalus

S. Niida, K. Urakami, S. Yoshida, 2017, Molecular medicine reports.

Expression of Ca2+-dependent activator protein for secretion 2 is increased in the brains of schizophrenic patients

Hiroshi Kunugi, Chisato Wakabayashi, Kunimasa Arima, 2011, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Reduced plasma orexin-A levels in patients with bipolar disorder

M. Ota, S. Yoshida, H. Kunugi, 2019, Neuropsychiatric disease and treatment.

Increased Matrix Metalloproteinases in Cerebrospinal Fluids of Patients With Major Depressive Disorder and Schizophrenia

Y. Okamoto, H. Kunugi, S. Boku, 2020, The international journal of neuropsychopharmacology.

Cerebrospinal fluid neuroplasticity-associated protein levels in patients with psychiatric disorders: a multiplex immunoassay study

M. Ota, S. Yoshida, H. Kunugi, 2020, Translational Psychiatry.

Plasma and cerebrospinal fluid G72 protein levels in schizophrenia and major depressive disorder

H. Kunugi, D. Sasayama, T. Nishikawa, 2017, Psychiatry Research.

Negative correlation between cerebrospinal fluid oxytocin levels and negative symptoms of male patients with schizophrenia

K. Arima, M. Ota, S. Yoshida, 2012, Schizophrenia Research.

Profiling of Cerebrospinal Fluid Lipids and Their Relationship with Plasma Lipids in Healthy Humans

M. Ota, Kosuke Saito, H. Kunugi, 2021, Metabolites.

Schizotypal trait in healthy women is associated with a shift away from dextrality on a spatial motor control task, but not on a force control task

M. Ota, H. Kunugi, H. Hori, 2012, Psychiatry Research.

More severe impairment of manual dexterity in bipolar disorder compared to unipolar major depression.

M. Ota, H. Kunugi, H. Hori, 2012, Journal of affective disorders.

Possible role of the dopamine D1 receptor in the sensorimotor gating deficits induced by high-fat diet

T. Numakawa, H. Kunugi, K. Hattori, 2015, Psychopharmacology.

Association of cognitive performance with interleukin-6 receptor Asp358Ala polymorphism in healthy adults

M. Ota, H. Kunugi, H. Hori, 2012, Journal of Neural Transmission.

Re-evaluation of soluble APP-α and APP-β in cerebrospinal fluid as potential biomarkers for early diagnosis of dementia disorders

K. Ishii, H. Matsuda, K. Arima, 2017, Biomarker Research.

Effects of ankyrin 3 gene risk variants on brain structures in patients with bipolar disorder and healthy subjects

M. Ota, H. Kunugi, H. Hori, 2016, Psychiatry and clinical neurosciences.

Psychological coping in depressed outpatients: association with cortisol response to the combined dexamethasone/CRH test.

M. Ota, H. Kunugi, H. Hori, 2014, Journal of affective disorders.

Exploring the genetic diversity of the Japanese population: Insights from a large-scale whole genome sequencing analysis

K. Ozaki, S. Niida, K. Miyo, 2023, bioRxiv.

Support for association between the Ser205Leu polymorphism of p75NTR and major depressive disorder

H. Kunugi, H. Hori, D. Sasayama, 2011, Journal of Human Genetics.

Modulation of cortisol responses to the DEX/CRH test by polymorphisms of the interleukin-1beta gene in healthy adults

M. Ota, H. Kunugi, H. Hori, 2011, Behavioral and Brain Functions.

Plasma Nervonic Acid Is a Potential Biomarker for Major Depressive Disorder: A Pilot Study

Koki Inoue, Kenji Kuroda, S. Yoshida, 2017, The international journal of neuropsychopharmacology.

Altered ethanolamine plasmalogen and phosphatidylethanolamine levels in blood plasma of patients with bipolar disorder

D. Goodenowe, Y. Yamazaki, M. Ota, 2019, Psychiatry and clinical neurosciences.

BMP4-SMAD1/5/9-RUNX2 pathway activation inhibits neurogenesis and oligodendrogenesis in Alzheimer’s patients’ iPSCs in senescence-related conditions

F. Kano, Daiki Nakatsu, M. Murata, 2023, Stem cell reports.

Discrimination of female schizophrenia patients from healthy women using multiple structural brain measures obtained with voxel‐based morphometry

Yasuhiro Nakata, Kiyotaka Nemoto, Yoshiya Moriguchi, 2012, Psychiatry and clinical neurosciences.

Relationship of temperament and character with cortisol reactivity to the combined dexamethasone/CRH test in depressed outpatients.

H. Kunugi, H. Hori, D. Sasayama, 2013, Journal of affective disorders.

Serum levels of glial cell line-derived neurotrophic factor as a biomarker for mood disorders and lithium response

K. Hashimoto, M. Iyo, Tadasu Horai, 2021, Psychiatry Research.

Reduced plasma orexin-A levels in patients with bipolar disorder

M. Ota, S. Yoshida, H. Kunugi, 2019 .

Personality in remitted major depressive disorder with single and recurrent episodes assessed with the Temperament and Character Inventory

M. Ota, H. Kunugi, H. Hori, 2015, Psychiatry and Clinical Neurosciences.

Metabolic profile alterations in the postmortem brains of patients with schizophrenia using capillary electrophoresis-mass spectrometry

Y. Ohashi, H. Kunugi, K. Hattori, 2017, Schizophrenia Research.

Cognitive effects of the ANK3 risk variants in patients with bipolar disorder and healthy individuals.

M. Ota, H. Kunugi, H. Hori, 2014, Journal of affective disorders.

Schizotypy and genetic loading for schizophrenia impact upon neuropsychological status in bipolar II and unipolar major depressive disorders.

H. Kunugi, H. Hori, D. Sasayama, 2012, Journal of affective disorders.

Relationships of Cerebrospinal Fluid Monoamine Metabolite Levels With Clinical Variables in Major Depressive Disorder.

M. Ota, H. Kunugi, D. Sasayama, 2017, Journal of Clinical Psychiatry.

Increased cerebrospinal fluid fibrinogen in major depressive disorder

M. Ota, S. Yoshida, H. Kunugi, 2015, Scientific Reports.

Discrepancy between Clinician-rated and Self-reported Depression Severity is Associated with Adverse Childhood Experience, Autistic-like Traits, and Coping Styles in Mood Disorders

S. Yoshida, H. Kunugi, H. Hori, 2023, Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology.

A latent profile analysis of schizotypy, temperament and character in a nonclinical population: association with neurocognition.

M. Ota, H. Kunugi, H. Hori, 2014, Journal of psychiatric research.

Temperament and character in remitted and symptomatic patients with schizophrenia: modulation by the COMT Val158Met genotype.

K. Arima, M. Ota, H. Kunugi, 2014, Journal of psychiatric research.

Hippocampal Fyn activity regulates extinction of contextual fear

S. Kida, T. Kohno, K. Hattori, 2009, Neuroreport.

Platelet-derived growth factor BB: A potential diagnostic blood biomarker for differentiating bipolar disorder from major depressive disorder.

K. Hashimoto, M. Iyo, Tadasu Horai, 2020, Journal of psychiatric research.

Schizotypal Personality in Healthy Adults Is Related to Blunted Cortisol Responses to the Combined Dexamethasone/ Corticotropin-Releasing Hormone Test

H. Kunugi, Y. Ozeki, H. Hori, 2011, Neuropsychobiology.

White matter abnormalities in major depressive disorder with melancholic and atypical features: A diffusion tensor imaging study

M. Ota, H. Kunugi, H. Hori, 2015, Psychiatry and clinical neurosciences.

Association of interleukin-1β genetic polymorphisms with cognitive performance in elderly females without dementia

M. Ota, H. Kunugi, H. Hori, 2011, Journal of Human Genetics.

FcɛRI-mediated mast cell degranulation requires calcium-independent microtubule-dependent translocation of granules to the plasma membrane

T. Yagi, R. Geha, T. Hirano, 2005, The Journal of cell biology.

N-Methyl-d-aspartate-induced c-Fos expression is enhanced in the forebrain structures related to emotion in Fyn-deficient mice

T. Yagi, K. Hattori, Toshio Sato, 2001, Brain Research.

Relationship of Handgrip Strength and Body Mass Index With Cognitive Function in Patients With Schizophrenia

M. Ota, H. Kunugi, K. Hattori, 2018, Front. Psychiatry.

Increased cerebrospinal fluid interleukin-6 levels in patients with schizophrenia and those with major depressive disorder.

K. Arima, M. Ota, S. Yoshida, 2013, Journal of Psychiatric Research.

Hippocampal Fyn activity regulates extinction of contextual fear

S. Kida, T. Kohno, K. Hattori, 2009, Neuroreport.

Effects of the CACNA1C risk allele on neurocognition in patients with schizophrenia and healthy individuals

Takashi Fujii, Miho Ota, Hiroshi Kunugi, 2012, Scientific Reports.

Altered Coupling of Regional Cerebral Blood flow and Brain Temperature in Schizophrenia Compared with Bipolar Disorder and Healthy Subjects

M. Ota, Kei Yamada, H. Kunugi, 2014, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Effect of electroconvulsive therapy on gray matter volume in major depressive disorder.

M. Ota, H. Kunugi, H. Hori, 2015, Journal of affective disorders.

Neuroanatomical basis of harm avoidance personality traits in major depressive disorder

M. Ota, Y. Yomogida, H. Kunugi, 2021, Journal of Affective Disorders Reports.

Plasma and cerebrospinal fluid G72 protein levels in schizophrenia and major depressive disorder

H. Kunugi, D. Sasayama, T. Nishikawa, 2017, Psychiatry Research.

Effect of l-theanine on glutamatergic function in patients with schizophrenia

M. Ota, H. Kunugi, H. Hori, 2015, Acta Neuropsychiatrica.

Possible association of Bifidobacterium and Lactobacillus in the gut microbiota of patients with major depressive disorder.

M. Ota, S. Yoshida, H. Kunugi, 2016, Journal of affective disorders.

Schizotypal trait in healthy women is associated with a shift away from dextrality on a spatial motor control task, but not on a force control task

M. Ota, H. Kunugi, H. Hori, 2012, Psychiatry Research.